Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Innovative Drug Delivery Nanophotonic Platform for Implementation of Sarcoma Therapy

NCT06599957 is registered in ClinicalTrials.gov with Istituto Ortopedico Rizzoli as lead sponsor.

NCT NCT06599957
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06599957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Innovative Drug Delivery Nanophotonic Platform for Implementation of Sarcoma Therapy
Lead sponsor
Istituto Ortopedico Rizzoli
Phase
Observational
Overall status
Recruiting
Start date
August 30, 2024
Completion date
August 30, 2026
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bone and soft tissue tumors